GlassScriptPhysician profile
Kailash Pant
NPI 1558857110
$10,650.31
in general payments reported to CMS, 2019-2025
23 companies · $5,729 in 2025
The $5,729 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $649 · 2022: $880 · 2023: $1,069 · 2024: $2,324 · 2025: $5,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,536 · Travel and Lodging: $4,516 · Education: $69.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,536.20 |
| Travel and Lodging | $4,515.61 |
| Education | $69.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,086.34 | 2022-2025 | Prostar, Optis, Supera |
| Abiomed | $2,048.40 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $1,666.08 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $658.87 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $543.44 | 2021-2025 | Lifevest |
| Medtronic, INC. | $274.68 | 2021-2024 | Azure Xt Dr Mri Surescan, Onyx Frontier |
| Shockwave Medical, INC | $145.41 | 2021-2025 | |
| Livanova USA, INC. | $133.10 | 2023 | Lifesparc |
| Penumbra, INC. | $128.90 | 2025 | Indigo System |
| Intuitive Surgical, INC. | $117.12 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.91 | 2024 | Jardiance |
| Philips North America LLC | $112.69 | 2022 | |
| Teleflex LLC | $96.00 | 2022 | |
| Getinge USA Sales, LLC | $85.36 | 2021-2024 | Cs300 Intra-Aortic Balloon Pump, English, 110v |
| Biosense Webster, INC. | $83.47 | 2023 | Na, Nuvision Ice Catheter, Soundstar |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $81.70 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $76.00 | 2021 | |
| Pfizer INC. | $57.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $44.59 | 2025 | |
| Cordis US Corp. | $35.83 | 2021-2023 | Mynxgrip |
| Bayer Healthcare Pharmaceuticals INC. | $26.43 | 2025 | |
| Amgen INC. | $17.40 | 2025 | Repatha |
| Kestra Medical Technology Services, INC. | $16.69 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kailash Pant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.